Kennedy, for one, has been vocally against the pharma industrys solutions to obesity, arguing instead that the focus should be on obesity prevention through healthy, non-processed foods and exercise
Our early data, 48 hours after opening pre-orders, suggests the pill is already reaching groups that carry a significant burden of obesity-related ill health but have historically been least likely to seek treatment: Adults in their 60s are buying the Wegovy pill at a rate 50% higher than they ever chose injectable treatment Adults in their 50s are the single largest group of pill buyers, accounting for 35% of total order volume, a third higher than their share of injectable orders Men are purchasing the pill at a rate 25% higher than they chose injectable treatment - significant for a group historically far less likely to seek weight loss medication at all Positive patient outcomes will have compounding benefits across the national healthcare system
Studies on rodents have shown GLP-1 receptor agonists can have antidepressant effects, but only with long-term use
Its name is Glutathione, and understanding how it functions reveals why many scientists consider it the one of most important molecules youve never heard of
Landmark trials have established GLP-1 RAs efficacy in reducing major adverse cardiovascular events (MACE) in patients with T2DM and atherosclerotic cardiovascular disease (ASCVD)